Luke Haslett

Luke Haslett is an accomplished professional in the field of genetic medicine and rare diseases, currently serving as the Director of Genetic Medicine at MiNA Therapeutics since August 2022. Prior to this role, Luke held positions at Novo Nordisk as a Specialist in Rare Diseases and at Evox Therapeutics Ltd, where responsibilities included Group Leader and Principal Research Scientist in rare diseases. Luke's academic journey began with a PhD in Biosciences from Cardiff University, where research focused on lysosomal storage disorders and neurodegenerative diseases, complemented by post-doctoral work on developing a small molecule therapy for Batten disease. Early career experiences include lab management at Cardiff University and placements at prestigious institutions such as the University of Oxford and St. Jude Children's Research Hospital.